(Q35692834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Use of psychopharmacologic agents in the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Abhilash K Desai

series ordinal

1

1 reference

9 August 2017

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

Clinics in geriatric medicine

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

697-719

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Drug therapy: drug disposition in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Use of antidepressants to treat depression in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Recovery in Geriatric Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Effects of serotonin on platelet activation in whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Antidepressant-induced sexual dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Treatment of chronic headache with antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

The effect of antidepressant treatment on chronic back pain: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Must we now consider SRIs neuroleptics?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Antidepressant discontinuation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Evidence of the dual mechanisms of action of venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Use of stimulants in the medically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Hyperprolactinaemia caused by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Dopamine antagonists and the development of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Risk factors of aspiration pneumonia in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Cataract occurrence with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Weight gain: side effect of atypical neuroleptics?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Mania in the geriatric patient population: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Low-dose lithium augmentation of divalproex in geriatric mania

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Pharmacologic loading in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Valproate-associated dysmyelopoiesis in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Cognitive improvement after benzodiazepine discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Generalized anxiety disorder in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Buspirone in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Zolpidem use and hip fractures in older people

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Treatment options for depression and psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

Psychopharmacology in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900044-2

7 January 2021

10.1016/S0749-0690(03)00044-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15024808%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference